Elbit Imaging Ltd. (EMITF)

Market Cap	9.00M
Revenue (ttm)	87,090
Net Income (ttm)	-4.82M
Shares Out	10.59M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.850
Previous Close	0.800
Day's Range	n/a
52-Week Range	0.800 - 1.250
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 30, 2012

About EMITF

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 27, 1996
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: EMITF

Financial Performance

Financial numbers in ILS